Clinical trials
Not yet recruiting Phase 2 Alzheimer Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 1 |
| 2025 | 7 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Imperial College London | 2 |
| BeyondBio Inc. | 1 |
| CellSight Technologies, Inc. | 1 |
| GE Healthcare | 1 |
| Hoffmann-La Roche | 1 |
| Institute for Molecular Medicine | 1 |
| Merry Life Biomedical Co., Ltd. | 1 |
| Neurocrine Biosciences | 1 |
| Neurology Office of South Florida | 1 |
| Plans4Care Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 18 |
| Cognitive Dysfunction | 4 |
| Dementia | 2 |
| Memory Disorders | 2 |
| Plaque, Amyloid | 2 |
| Disease | 1 |
| Encephalitis | 1 |
| Heredodegenerative Disorders, Nervous System | 1 |
| Insulin Resistance | 1 |
| Neurodegenerative Diseases | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.